Table of Contents To provide income distribution and / or medium to long term capital gains. Investments would be focused towards mid-cap stocks. TATA Mid Cap Growth Fund is a Equity - Mid Cap fund launched on 1 Jul 94. It is a fund with Moderately High risk and has given a Below is the key information for TATA Mid Cap Growth Fund Returns up to 1 year are on Historical performance (Yearly) on absolute basis TATA Mid Cap Growth Fund - G
Scheme Objective
CAGR
return of 13.3% since its launch. Ranked 31 in Mid Cap
category. Return for 2023 was 40.5% , 2022 was 0.6% and 2021 was 40% . NAV as on 11 Oct 24 ₹443.143 ↑ 1.28 (0.29 %) Net Assets (AUM) as on 31 Aug 2024 ₹4,514 Cr. Launch Date 1 Jul 1994 Category Equity - Mid Cap Rating ☆☆ Type Open Ended Fund Risk Moderately High AMC Tata Asset Management Limited Alpha Ratio 2.68 Expense Ratio 0.0 % Sharpe Ratio 2.68 Information Ratio -0.89 Benchmark Not Available Min Investment ₹5,000 Min SIP Investment ₹150 Exit Load 0-365 Days (1%),365 Days and above(NIL) NAV Price Chart
Returns
Annual Compounded Returns
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 11 Oct 24 Duration Returns 1 Month -1.4% 3 Month 0.3% 6 Month 16.2% 1 Year 41.7% 3 Year 21.2% 5 Year 27.1% 10 Year 15 Year Since launch 13.3% Historical Annual Returns
Year Returns 2023 40.5% 2022 0.6% 2021 40% 2020 24.3% 2019 6.5% 2018 -13% 2017 49.8% 2016 -2.2% 2015 10.8% Growth of 10k Over Years
Date Value 30 Sep 19 ₹10,000 30 Sep 20 ₹10,732 30 Sep 21 ₹17,491 30 Sep 22 ₹17,807 30 Sep 23 ₹22,705 30 Sep 24 ₹33,288 Asset Allocation
Asset Class Value Cash 2.23% Equity 97.77% Sector Allocation
Sector Value Industrials 29.5% Financial Services 19.27% Health Care 13.44% Consumer Cyclical 9.25% Basic Materials 7.69% Real Estate 5.39% Technology 4.07% Consumer Defensive 3.13% Communication Services 3.13% Energy 1.6% Utility 1.31% Top Securities Holdings / Portfolio
Holdings/Securities
Name Global Industry Holding Value Quantity Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Jun 23 | AUROPHARMADrug Manufacturers - Specialty & Generic 3% ₹157 Cr 1,000,000 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 21 | 539523Drug Manufacturers - Specialty & Generic 3% ₹154 Cr 250,000 Cummins India Ltd (Industrials)
Equity, Since 31 Mar 21 | CUMMINSINDSpecialty Industrial Machinery 3% ₹138 Cr 369,694 Muthoot Finance Ltd (Financial Services)
Equity, Since 30 Apr 24 | 533398Credit Services 3% ₹133 Cr 675,000
↑ 50,000 Max Financial Services Ltd (Financial Services)
Equity, Since 30 Nov 23 | 500271Insurance - Life 3% ₹130 Cr 1,206,000
↑ 206,000 UNO Minda Ltd (Consumer Cyclical)
Equity, Since 31 Mar 21 | 532539Auto Parts 3% ₹117 Cr 1,000,000 PI Industries Ltd (Basic Materials)
Equity, Since 31 Dec 15 | PIINDAgricultural Inputs 2% ₹112 Cr 250,000 Lupin Ltd (Healthcare)
Equity, Since 31 Dec 22 | 500257Drug Manufacturers - Specialty & Generic 2% ₹112 Cr 500,000 JSW Infrastructure Ltd (Industrials)
Equity, Since 30 Sep 23 | 543994Marine Shipping 2% ₹101 Cr 3,100,000 Thermax Ltd (Industrials)
Equity, Since 30 Apr 21 | 500411Conglomerates 2% ₹95 Cr 217,412
Talk to our investment specialistFund Managers
Name Since Tenure Satish Mishra 9 Mar 21 3.48 Yr. Custodians
Company Address Deutsche Bank AG Deutsche Bank AG,Kodak House, 22, D.N. Road, Registrar & Transfer Agent
Computer Age Management Services Ltd Address New No.10, Old No.178,,Kodambakkam High Road,,Opp. Hotel Palmgrove,,Nungambakkam FAX 91-44-28283610 Email enq_L@camsonline.com Administrator Companies
Company Address Tata Mutual Fund 1903, B-Wing, Parinee Crescenzo,,G-Block, Bandra Kurla Complex, Bandra East Mumbai 400051 Auditors
Company Address Deloitte Haskins & Sells LLP 12, Dr. Annie Besant Road, Opp. Shiv Sagar Estate,,Worli M/s BSR & Co. KPMG House, Kamala Mills Compound,448 Senapati Bapat Marg,Lower Parel All Plan & Options
Fund and Plan NAV 6 Month 1 Year 3 Year 5 Year TATA Mid Cap Growth Fund
Growth ₹443.143
↑ 1.28 16.19 % 41.72 % 21.18 % 27.07 % TATA Mid Cap Growth Fund
Normal Dividend, Reinvestment ₹122.314
↑ 0.35 16.19 % 41.72 % 21.12 % 27 % TATA Mid Cap Growth Fund
Normal Dividend, Payout ₹122.314
↑ 0.35 16.19 % 41.72 % 21.12 % 27 % Data as on 11 Oct 24